Bristol Myers Squibb Co. Stock Rises Tuesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) inched 0.86% higher to $72.65 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.46% to 4,076.60 and the Dow Jones Industrial Average rising 1.09% to 34,086.04. The stock's rise snapped a three-day losing streak. Bristol Myers Squibb Co. closed $8.79 below its 52-week high ($81.44), which the company achieved on December 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.88% to $163.42, Pfizer Inc. (PFE) rose 1.40% to $44.16, and Abbott Laboratories (ABT) rose 0.67% to $110.55. Trading volume (9.3 M) eclipsed its 50-day average volume of 8.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 31, 2023.
(END) Dow Jones Newswires
January 31, 2023 16:41 ET (21:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.